Thursday - June 25, 2026

Category Archives: Financial Market

Idiopathic Pulmonary Fibrosis Market is Expected to Surpass USD 7 Billion by 2036, Driven by Rising Disease Burden and Emerging Disease-Modifying Therapies | DelveInsight

The Idiopathic Pulmonary Fibrosis Market is witnessing substantial growth driven by increasing disease prevalence, improving diagnostic capabilities, growing awareness among healthcare professionals, and expanding adoption of antifibrotic therapies. The anticipated launch of emerging therapies such as Deupirfenidone, Admilparant, NIKTIMVO, and … Continue reading →

Peraso (NASDAQ: PRSO) Could Be One of the Most Overlooked AI Infrastructure and Military Drone Stocks Under $1 – More Stocks Inside

While much of Wall Street’s attention remains focused on artificial intelligence giants and multi-billion-dollar semiconductor companies, Peraso Inc. (NASDAQ: PRSO) continues to quietly build a position in several of the fastest-growing technology markets, including military drones, AI infrastructure, autonomous systems, … Continue reading →

Andy Nematalla Expands Insights Series with New Commentary on Global Investment and Commercial Growth

Andy Nematalla is a global business and investment executive with more than two decades of experience building, scaling, and advising companies across international markets. Andy Nematalla shares insights on commercialization, strategic partnerships, and building sustainable business growth. Andy Nematalla, a … Continue reading →

Bitcoin Miners HIVE, BTBT, ANY, CAN, ABTC, KEEL Emerging as Future AI Infrastructure Leaders, Offering Investors Significant Upside Potential — See Why

As the Artificial Intelligence (AI) revolution accelerates, a growing number of Bitcoin Mining companies are transforming their business models to capitalize on one of the fastest-growing sectors in technology: AI Data Centers, High-Performance Computing (HPC), GPU Infrastructure, Cloud Computing, and … Continue reading →

IGC Pharma’s (NYSE American: IGC) AI Platform Cuts Alzheimer’s Research by 90%, Accelerating Drug Discovery

IGC Pharma, Inc. (NYSE: IGC) a clinical-stage Biotechnology company developing treatments for Alzheimer’s Disease and Artificial Intelligence (AI) enabled healthcare technologies, today announced the beta release of its proprietary Agentic Harmonization Assistant (“AHA”), a patent-pending Healthcare AI platform designed to … Continue reading →